{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:20:55Z","timestamp":1783441255190,"version":"3.54.6"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.canlet.2026.218586","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:17:22Z","timestamp":1780586242000},"page":"218586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanomedicine orchestrated metabolic reprogramming of immune cells in antitumor immunity"],"prefix":"10.1016","volume":"656","author":[{"given":"Anqi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9213-8343","authenticated-orcid":false,"given":"Jiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-2045","authenticated-orcid":false,"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","article-title":"Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery","volume":"24","author":"Sabit","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/imm3.70007","article-title":"The future of cancer therapy: nanomaterials and tumor microenvironment","volume":"1","author":"Chen","year":"2025","journal-title":"iMetaMed"},{"issue":"10","key":"10.1016\/j.canlet.2026.218586_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70041","article-title":"Synergistical induction of apoptosis via cold atmospheric plasma and nanohydroxyapatite for selective inhibition of oral squamous cell carcinoma in tumour microenvironment","volume":"58","author":"Qi","year":"2025","journal-title":"Cell Prolif."},{"issue":"24","key":"10.1016\/j.canlet.2026.218586_bib4","article-title":"Efficient delivery of lomitapide using hybrid membrane-coated tetrahedral DNA nanostructures for glioblastoma therapy","volume":"36","author":"Song","year":"2024","journal-title":"Adv Mater Deerfield Beach Fla"},{"issue":"4","key":"10.1016\/j.canlet.2026.218586_bib5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/acs.molpharmaceut.9b01159","article-title":"Facile construction of i-motif DNA-conjugated gold nanostars as near-infrared and pH dual-responsive targeted drug delivery systems for combined cancer therapy","volume":"17","author":"Miao","year":"2020","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.canlet.2026.218586_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218586_bib7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jconrel.2020.10.014","article-title":"Carrier-free nanodrugs for safe and effective cancer treatment","volume":"329","author":"Karaosmanoglu","year":"2021","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"11","key":"10.1016\/j.canlet.2026.218586_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218586_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70070","article-title":"The microbiome in cancer","volume":"4","author":"Lin","year":"2025","journal-title":"iMeta"},{"key":"10.1016\/j.canlet.2026.218586_bib10","doi-asserted-by":"crossref","unstructured":"Lai M, Shao W, Mao J, Ye Q. Revolution in cell therapy: in vivo chimeric-antigen-receptor-T-cell therapy breakthroughs and promises for the future. Research. 8:917. doi:10.34133\/research.0917 PubMed PMID: 41079670; PubMed Central PMCID: PMC12509061.","DOI":"10.34133\/research.0917"},{"key":"10.1016\/j.canlet.2026.218586_bib11","doi-asserted-by":"crossref","unstructured":"Lin A, Ye P, Li Z, Jiang A, Liu Z, Cheng Q, et al. Natural killer cell immune checkpoints and their therapeutic targeting in cancer treatment. Research. 8:723. doi:10.34133\/research.0723 PubMed PMID: 40463500; PubMed Central PMCID: PMC12131497.","DOI":"10.34133\/research.0723"},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.130","article-title":"HPVTIMER: a shiny web application for tumor immune estimation in human papillomavirus-associated cancers","volume":"2","author":"Liu","year":"2023","journal-title":"iMeta"},{"issue":"7","key":"10.1016\/j.canlet.2026.218586_bib13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41401-020-0400-z","article-title":"Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy","volume":"41","author":"Gao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.canlet.2026.218586_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218586_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13622","article-title":"Dendritic cell-targeted delivery of antigens using extracellular vesicles for anti-cancer immunotherapy","volume":"57","author":"Dang","year":"2024","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.apsb.2021.09.010","article-title":"The generation of PD-L1 and PD-L2 in cancer cells: from nuclear chromatin reorganization to extracellular presentation","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.canlet.2026.218586_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13702","article-title":"Abnormal HCK\/glutamine\/autophagy axis promotes endometriosis development by impairing macrophage phagocytosis","volume":"57","author":"Lei","year":"2024","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.canlet.2026.218586_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/mef2.89","article-title":"Unraveling the influence of metabolic signatures on immune dynamics for predicting immunotherapy response and survival in cancer","volume":"3","author":"Ou","year":"2024","journal-title":"MedComm \u2013 Future Med"},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11684-025-1126-6","article-title":"Burning lactic acid: a road to revitalizing antitumor immunity","volume":"19","author":"Ma","year":"2025","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.canlet.2026.218586_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","article-title":"Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen","volume":"21","author":"Vardhana","year":"2020","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218586_bib21","first-page":"2504","article-title":"Excitotoxicity, oxytosis\/ferroptosis, and neurodegeneration: emerging insights into mitochondrial mechanisms","volume":"16","author":"Khan","year":"2024","journal-title":"Aging Dis"},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.21147\/j.issn.1000-9604.2025.03.12","article-title":"Tumor-educated cells in tumor microenvironment: key drivers of immunotherapy resistance","volume":"37","author":"Zou","year":"2025","journal-title":"Chin. J. Cancer Res."},{"issue":"7858","key":"10.1016\/j.canlet.2026.218586_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"issue":"36","key":"10.1016\/j.canlet.2026.218586_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202101410","article-title":"Second near\u2010infrared light\u2010activatable polymeric nanoantagonist for photothermal immunometabolic cancer therapy","volume":"33","author":"Xu","year":"2021","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12943-024-02186-6","article-title":"Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform \u2018cold\u2019 tumors into \u2018hot\u2019 tumors","volume":"23","author":"Ying","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/0929867327666200130103206","article-title":"The emerging roles of exosomes in the chemoresistance of hepatocellular carcinoma","volume":"28","author":"Zhang","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","article-title":"Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells","volume":"17","author":"Saha","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"47","key":"10.1016\/j.canlet.2026.218586_bib29","article-title":"Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles","volume":"32","author":"Rao","year":"2020","journal-title":"Adv Mater Deerfield Beach Fla"},{"issue":"9","key":"10.1016\/j.canlet.2026.218586_bib30","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/pharmaceutics13091493","article-title":"M1 macrophage-derived exosomes loaded with gemcitabine and deferasirox against chemoresistant pancreatic cancer","volume":"13","author":"Zhao","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2026.218586_bib31","doi-asserted-by":"crossref","unstructured":"Li X, Zhang R, Yang Y, Huang W. Finely tailored conjugated small molecular nanoparticles for near-infrared biomedical applications. Research. 8:534. doi:10.34133\/research.0534 PubMed PMID: 39801503; PubMed Central PMCID: PMC11717998.","DOI":"10.34133\/research.0534"},{"issue":"14","key":"10.1016\/j.canlet.2026.218586_bib32","article-title":"Personalized cancer nanomedicine: overcoming biological barriers for intracellular delivery of biopharmaceuticals","volume":"36","author":"L\u00f3pez-Est\u00e9vez","year":"2024","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"10.1016\/j.canlet.2026.218586_bib33","first-page":"330","article-title":"Engineering customized nanovaccines for enhanced cancer immunotherapy","volume":"36","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"issue":"19","key":"10.1016\/j.canlet.2026.218586_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417198","article-title":"Hetero-trimetallic atom catalysts enable targeted ROS generation and redox signaling for intensive apoptosis and ferroptosis","volume":"37","author":"Li","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-023-01797-9","article-title":"Nanomaterials in tumor immunotherapy: new strategies and challenges","volume":"22","author":"Zhu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218586_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jconrel.2024.06.066","article-title":"Multi-modal Ca2+ nanogenerator via reversing T cell exhaustion for enhanced chemo-immunotherapy","volume":"372","author":"An","year":"2024","journal-title":"J Control Release Off J Control Release Soc."},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-024-01972-6","article-title":"CTLs heterogeneity and plasticity: implications for cancer immunotherapy","volume":"23","author":"Peng","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40820-020-00555-6","article-title":"Nanoparticle-mediated lipid metabolic reprogramming of T cells in tumor microenvironments for immunometabolic therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Nano-Micro Lett."},{"issue":"24","key":"10.1016\/j.canlet.2026.218586_bib40","doi-asserted-by":"crossref","first-page":"24947","DOI":"10.1021\/acsnano.3c06784","article-title":"Dendritic cell-based in situ nanovaccine for reprogramming lipid metabolism to boost tumor immunotherapy","volume":"17","author":"Qin","year":"2023","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.canlet.2026.218586_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3892\/ijmm.2023.5337","article-title":"Emerging nanomaterials targeting macrophage adapted to abnormal metabolism in cancer and atherosclerosis therapy","volume":"53","author":"Xu","year":"2024","journal-title":"Int. J. Mol. Med."},{"issue":"24","key":"10.1016\/j.canlet.2026.218586_bib42","doi-asserted-by":"crossref","first-page":"27651","DOI":"10.1021\/acsami.2c05533","article-title":"Designing lactate dehydrogenase-mimicking SnSe nanosheets to reprogram tumor-associated macrophages for potentiation of photothermal immunotherapy","volume":"14","author":"Ling","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.canlet.2026.218586_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201569","article-title":"Pre-induced ICD membrane-coated carrier-free nanoparticles for the personalized lung cancer immunotherapy","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.canlet.2026.218586_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105301","article-title":"Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective","volume":"107","author":"Liu","year":"2024","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.hlife.2024.11.001","article-title":"Myeloid cell diversity: from fundamental biology to disease states","volume":"2","author":"Ballesteros","year":"2024","journal-title":"hLife"},{"issue":"36","key":"10.1016\/j.canlet.2026.218586_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403663","article-title":"Dual adjuvant-loaded peptide antigen self-assembly potentiates dendritic cell-mediated tumor immunotherapy","volume":"11","author":"Kim","year":"2024","journal-title":"Adv. Sci."},{"issue":"23","key":"10.1016\/j.canlet.2026.218586_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311574","article-title":"Supramolecular lipid nanoparticles based on host-guest recognition: a new generation delivery system of mRNA vaccines for cancer immunotherapy","volume":"36","author":"Qi","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2026.218586_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.03.034","article-title":"Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity","volume":"130","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218586_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122104","article-title":"Regulating T-cell metabolic reprogramming and blocking PD-1 co-promote personalized postoperative autologous nanovaccines","volume":"297","author":"Chang","year":"2023","journal-title":"Biomaterials"},{"issue":"49","key":"10.1016\/j.canlet.2026.218586_bib50","doi-asserted-by":"crossref","first-page":"19902","DOI":"10.1073\/pnas.1313152110","article-title":"Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose","volume":"110","author":"de Titta","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218586_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbae036","article-title":"A lipid\/PLGA nanocomplex to reshape tumor immune microenvironment for colon cancer therapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Regen. Biomater."},{"issue":"8","key":"10.1016\/j.canlet.2026.218586_bib52","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1016\/j.apsb.2024.03.010","article-title":"Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib53","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41565-024-01758-3","article-title":"Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade","volume":"19","author":"Tan","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"35","key":"10.1016\/j.canlet.2026.218586_bib54","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1021\/acs.nanolett.4c01610","article-title":"Acidity-actuated polymer\/calcium phosphate hybrid nanomotor (PCaPmotor) for penetrating drug delivery and synergistic anticancer immunotherapy","volume":"24","author":"Xu","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.canlet.2026.218586_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jconrel.2024.07.063","article-title":"\u201call-in-one\u201d metal polyphenol network nanocapsules integrated microneedle patches for lipophagy fueled ferroptosis-mediated multimodal therapy","volume":"373","author":"Wang","year":"2024","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.canlet.2026.218586_bib56","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.2147\/IJN.S452548","article-title":"Dual-mRNA delivery using tumor cell lysate-based multifunctional nanoparticles as an efficient colon cancer immunogene therapy","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.canlet.2026.218586_bib57","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1021\/acsami.3c16813","article-title":"Improved immune response for colorectal cancer therapy triggered by multifunctional nanocomposites with self-amplifying antitumor ferroptosis","volume":"16","author":"Lin","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"36","key":"10.1016\/j.canlet.2026.218586_bib58","doi-asserted-by":"crossref","first-page":"42209","DOI":"10.1021\/acsami.3c07648","article-title":"Lipid-polymer hybrid nanoparticles with both PD-L1 knockdown and mild photothermal effect for tumor photothermal immunotherapy","volume":"15","author":"Chuan","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"44","key":"10.1016\/j.canlet.2026.218586_bib59","article-title":"A trojan-horse-like biomimetic nano-NK to elicit an immunostimulatory tumor microenvironment for enhanced GBM chemo-immunotherapy","volume":"19","author":"Zhang","year":"2023","journal-title":"Small Weinh Bergstr Ger"},{"issue":"7","key":"10.1016\/j.canlet.2026.218586_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009368","article-title":"Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy","volume":"12","author":"Al-Janabi","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12951-023-01949-5","article-title":"Oral membrane-biomimetic nanoparticles for enhanced endocytosis and regulation of tumor-associated macrophage","volume":"21","author":"Gu","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218586_bib62","article-title":"Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"24","key":"10.1016\/j.canlet.2026.218586_bib63","doi-asserted-by":"crossref","first-page":"15557","DOI":"10.1021\/acsnano.4c00392","article-title":"Dual-targeted self-adjuvant heterocyclic Lipidoid@Polyester hybrid nanovaccines for boosting cancer immunotherapy","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib64","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1038\/s41467-023-43079-4","article-title":"Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"36","key":"10.1016\/j.canlet.2026.218586_bib65","article-title":"Precise engineering of a Se\/Te nanochaperone for reinvigorating cancer radio-immunotherapy","volume":"35","author":"Chang","year":"2023","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"10.1016\/j.canlet.2026.218586_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2022.11.054","article-title":"A biomimetic metal-organic framework nanosystem modulates immunosuppressive tumor microenvironment metabolism to amplify immunotherapy","volume":"353","author":"Wang","year":"2023","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.canlet.2026.218586_bib67","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2147\/IJN.S442446","article-title":"IL-12-overexpressed nanoparticles suppress the proliferation of melanoma through inducing ICD and activating DC, CD8+ T, and CD4+ T cells","volume":"19","author":"Shen","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"23","key":"10.1016\/j.canlet.2026.218586_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202401250","article-title":"Activable nano-immunomodulator assembled from \u03c0-extended naphthalenediimide for precision photothermal immunotherapy","volume":"63","author":"Zhong","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"19","key":"10.1016\/j.canlet.2026.218586_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm9561","article-title":"Biomimetic piezoelectric nanomaterial-modified oral microrobots for targeted catalytic and immunotherapy of colorectal cancer","volume":"10","author":"Fan","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218586_bib70","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jcis.2024.01.129","article-title":"A lactate-depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy","volume":"660","author":"Zhou","year":"2024","journal-title":"J. Colloid Interface Sci."},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib71","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1039\/D2TB00197G","article-title":"Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer","volume":"10","author":"Zang","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.canlet.2026.218586_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213425","article-title":"Tumor immunosuppression relief via acidity modulation combined PD-L1 siRNA for enhanced immunotherapy","volume":"150","author":"Tang","year":"2023","journal-title":"Biomater. Adv."},{"issue":"22","key":"10.1016\/j.canlet.2026.218586_bib73","article-title":"Regulation of CTLs\/tregs via highly stable and ultrasound-responsive cerasomal nano-modulators for enhanced colorectal cancer immunotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger."},{"key":"10.1016\/j.canlet.2026.218586_bib74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biomaterials.2015.11.040","article-title":"Self-adjuvanted nanovaccine for cancer immunotherapy: role of lysosomal rupture-induced ROS in MHC class I antigen presentation","volume":"79","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218586_bib75","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.actbio.2023.09.013","article-title":"Monophosphoryl lipid a-assembled nanovaccines enhance tumor immunotherapy","volume":"171","author":"Li","year":"2023","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-023-01900-8","article-title":"CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"30","key":"10.1016\/j.canlet.2026.218586_bib77","article-title":"Slimming and reinvigorating tumor-associated dendritic cells with hierarchical lipid rewiring nanoparticles","volume":"35","author":"Xu","year":"2023","journal-title":"Adv Mater Deerfield Beach Fla"},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib78","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1016\/j.apsb.2022.05.032","article-title":"Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"Pt A","key":"10.1016\/j.canlet.2026.218586_bib79","article-title":"Combination of a cationic complexes loaded with mRNA and \u03b1-galactose ceramide enhances antitumor immunity and affects the tumor immune microenvironment","volume":"113","author":"Guo","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.canlet.2026.218586_bib80","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2017.11.020","article-title":"Extending antigen release from particulate vaccines results in enhanced antitumor immune response","volume":"269","author":"Kapadia","year":"2018","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"40","key":"10.1016\/j.canlet.2026.218586_bib81","article-title":"Encapsulation of hydrophilic and hydrophobic peptides into hollow mesoporous silica nanoparticles for enhancement of antitumor immune response","volume":"13","author":"Xie","year":"2017","journal-title":"Small Weinh Bergstr Ger"},{"key":"10.1016\/j.canlet.2026.218586_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2016.05.008","article-title":"A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity","volume":"233","author":"Shen","year":"2016","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.canlet.2026.218586_bib83","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jconrel.2024.07.051","article-title":"Engineering CaP-pickering emulsion for enhanced mRNA cancer vaccines via dual DC and NK activations","volume":"373","author":"Wu","year":"2024","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.canlet.2026.218586_bib84","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.2147\/IJN.S449820","article-title":"Synergistic photothermal tumor immunotherapy by 1-MT based on zeolitic imidazolate framework-8 with pH-high sensitivity","volume":"19","author":"Su","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"34","key":"10.1016\/j.canlet.2026.218586_bib85","doi-asserted-by":"crossref","first-page":"23001","DOI":"10.1021\/acsnano.4c04553","article-title":"Boost infiltration and activity of T cells via inhibiting ecto-5\u2019-nucleotidase (CD73) immune checkpoint to enhance glioblastoma immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218586_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102048","article-title":"Therapeutic potential of tLyp-1-EV-shCTCF in inhibiting liver cancer stem cell self-renewal and immune escape via SALL3 modulation in hepatocellular carcinoma","volume":"49","author":"Zhu","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218586_bib87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2024.07.020","article-title":"Lipid-coated gold nanorods for photoimmunotherapy of primary breast cancer and the prevention of metastasis","volume":"373","author":"Kim","year":"2024","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"25","key":"10.1016\/j.canlet.2026.218586_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn8079","article-title":"Supramolecular artificial nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218586_bib89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.34133\/bmr.0038","article-title":"Cell membrane hybrid lipid nanovesicles enhance innate immunity for synergistic immunotherapy by promoting immunogenic cell death and cGAS activation","volume":"28","author":"Qian","year":"2024","journal-title":"Biomater. Res."},{"key":"10.1016\/j.canlet.2026.218586_bib90","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2024.04.052","article-title":"Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria","volume":"370","author":"Meulewaeter","year":"2024","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"15","key":"10.1016\/j.canlet.2026.218586_bib91","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1021\/acsami.4c00513","article-title":"Metabolic modulation of kynurenine based on kynureninase-loaded nanoparticle depot overcomes tumor immune evasion in cancer immunotherapy","volume":"16","author":"Chae","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.canlet.2026.218586_bib92","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41565-024-01615-3","article-title":"Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination","volume":"19","author":"Zeng","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218586_bib93","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1021\/jacs.3c08622","article-title":"Single-site nanozymes with a highly conjugated coordination structure for antitumor immunotherapy via cuproptosis and cascade-enhanced T lymphocyte activity","volume":"146","author":"Liu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12967-024-05104-y","article-title":"Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218586_bib95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2022.04.048","article-title":"ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy","volume":"347","author":"Wei","year":"2022","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"35","key":"10.1016\/j.canlet.2026.218586_bib96","doi-asserted-by":"crossref","first-page":"23941","DOI":"10.1021\/acsnano.3c10588","article-title":"Tumor metabolism aiming Cu2-xS nanoagents mediate photothermal-derived cuproptosis and immune activation","volume":"18","author":"Zu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218586_bib97","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2024.06.059","article-title":"Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation","volume":"372","author":"Zafar","year":"2024","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"6","key":"10.1016\/j.canlet.2026.218586_bib98","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1021\/acsami.3c17357","article-title":"Inflammation-driven nanohitchhiker enhances postoperative immunotherapy by alleviating prostaglandin E2-mediated immunosuppression","volume":"16","author":"Liu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.canlet.2026.218586_bib99","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1021\/acsnano.1c09794","article-title":"Nano-codelivery of temozolomide and siPD-L1 to reprogram the drug-resistant and immunosuppressive microenvironment in orthotopic glioblastoma","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.canlet.2026.218586_bib100","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.7150\/thno.57803","article-title":"An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment","volume":"11","author":"Hsieh","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218586_bib101","article-title":"Antitumor effect and immune response of nanosecond pulsed electric fields in pancreatic cancer","volume":"10","author":"Zhao","year":"2020","journal-title":"Front. Oncol."},{"issue":"49","key":"10.1016\/j.canlet.2026.218586_bib102","doi-asserted-by":"crossref","first-page":"54399","DOI":"10.1021\/acsami.0c15522","article-title":"Employing ATP as a new adjuvant promotes the induction of robust antitumor cellular immunity by a PLGA nanoparticle vaccine","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"29","key":"10.1016\/j.canlet.2026.218586_bib103","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab824d","article-title":"An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy","volume":"31","author":"Hu","year":"2020","journal-title":"Nanotechnology"},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib104","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ymthe.2018.11.012","article-title":"Nanoparticle delivery of RIG-I agonist enables effective and safe adjuvant therapy in pancreatic cancer","volume":"27","author":"Das","year":"2019","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"10.1016\/j.canlet.2026.218586_bib105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2018.10.022","article-title":"Gemcitabine nanoparticles promote antitumor immunity against melanoma","volume":"189","author":"Zhang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218586_bib106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2016.11.013","article-title":"Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment","volume":"245","author":"Huo","year":"2017","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"19","key":"10.1016\/j.canlet.2026.218586_bib107","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1039\/D3BM01265D","article-title":"Dual-responsive PEG-lipid polyester nanoparticles for siRNA and vaccine delivery elicit anti-cancer immune responses by modulating tumor microenvironment","volume":"11","author":"Liu","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.canlet.2026.218586_bib108","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jconrel.2024.05.017","article-title":"Electrically activated polymetallic nanocrystals for long-term tumor suppression via oxygen-independent ROS generation and electro-immunotherapy","volume":"370","author":"Wang","year":"2024","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.canlet.2026.218586_bib109","article-title":"Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"32","key":"10.1016\/j.canlet.2026.218586_bib110","doi-asserted-by":"crossref","first-page":"22455","DOI":"10.1021\/jacs.4c05650","article-title":"Radiotherapy-driven nanoprobes targeting for visualizing tumor infiltration dynamics and inducing ferroptosis in myeloid-derived suppressor cells","volume":"146","author":"Zhu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib111","first-page":"475","article-title":"A bacterial and ganglioside-based nanoparticle initiates reprogramming of macrophages and promotes antitumor phenotypes","volume":"212","author":"Alvarez-Arzola","year":"1950","journal-title":"J Immunol Baltim Md"},{"issue":"13","key":"10.1016\/j.canlet.2026.218586_bib112","doi-asserted-by":"crossref","first-page":"14887","DOI":"10.1021\/acsami.1c23274","article-title":"Dual-targeting of tumor cells and tumor-associated macrophages by palmitic acid modified albumin nanoparticles for antitumor and antimetastasis therapy","volume":"14","author":"Feng","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2026.218586_bib113","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2018.12.041","article-title":"Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells","volume":"295","author":"Ledo","year":"2019","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"13","key":"10.1016\/j.canlet.2026.218586_bib114","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.7150\/thno.19987","article-title":"Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing antitumor efficiency","volume":"7","author":"Kong","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40580-024-00441-6","article-title":"Mechanism exploration of synergistic photo-immunotherapy strategy based on a novel exosome-like nanosystem for remodeling the immune microenvironment of HCC","volume":"11","author":"Chen","year":"2024","journal-title":"Nano Converg."},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib116","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1039\/D4BM00490F","article-title":"Acidity-responsive polyphenol-coordinated nanovaccines for improving tumor immunotherapy via bidirectional reshaping of the immunosuppressive microenvironment and controllable release of antigens","volume":"12","author":"Qiu","year":"2024","journal-title":"Biomater. Sci."},{"issue":"42","key":"10.1016\/j.canlet.2026.218586_bib117","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1039\/C9NR03353J","article-title":"Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages","volume":"11","author":"Han","year":"2019","journal-title":"Nanoscale"},{"issue":"28","key":"10.1016\/j.canlet.2026.218586_bib118","article-title":"Chiral ruthenium nanozymes with self-cascade reaction driven the NO generation induced macrophage M1 polarization realizing the lung cancer \u201ccocktail therapy.\u201d","volume":"19","author":"Chen","year":"2023","journal-title":"Small Weinh Bergstr Ger"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib119","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.canlet.2026.218586_bib120","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1039\/D2TB00794K","article-title":"Cationic poly(amino acid) surface functionalized manganese nanoparticles for nitric oxide-based immunotherapy and magnetic resonance imaging","volume":"10","author":"Lim","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib121","article-title":"Translational nanotherapeutics reprograms immune microenvironment in malignant pleural effusion of lung adenocarcinoma","volume":"10","author":"Song","year":"2021","journal-title":"Adv. Healthcare Mater."},{"issue":"29","key":"10.1016\/j.canlet.2026.218586_bib122","article-title":"Necroptosis-mediated synergistic photodynamic and glutamine-metabolic therapy enabled by a biomimetic targeting nanosystem for cholangiocarcinoma","volume":"11","author":"Zheng","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger."},{"issue":"4","key":"10.1016\/j.canlet.2026.218586_bib123","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2017.10.050","article-title":"Nanoliposome C6-ceramide increases the anti-tumor immune response and slows growth of liver tumors in mice","volume":"154","author":"Li","year":"2018","journal-title":"Gastroenterology"},{"issue":"34","key":"10.1016\/j.canlet.2026.218586_bib124","article-title":"Reshaping intratumoral mononuclear phagocytes with antibody-opsonized immunometabolic nanoparticles","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"10.1016\/j.canlet.2026.218586_bib125","article-title":"The effect of hypoxia-induced exosomes on anti-tumor immunity and its implication for immunotherapy","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Immunol."},{"issue":"26","key":"10.1016\/j.canlet.2026.218586_bib126","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1016\/j.biomaterials.2012.05.011","article-title":"Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(\u03b3-glutamic acid) nanoparticles","volume":"33","author":"Broos","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib127","article-title":"At the crossroads of TNF \u03b1 signaling and cancer","volume":"17","author":"Manohar","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218586_bib128","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.7314\/APJCP.2015.16.9.3917","article-title":"Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1\/m2 macrophage balance in the tumor microenvironment","volume":"16","author":"Shiri","year":"2015","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"36","key":"10.1016\/j.canlet.2026.218586_bib129","article-title":"Interference of ATP-adenosine axis by engineered biohybrid for amplifying immunogenic cell death-mediated antitumor immunotherapy","volume":"36","author":"Deng","year":"2024","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"10.1016\/j.canlet.2026.218586_bib130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12951-024-02643-w","article-title":"Potentiating dual-directional immunometabolic regulation with nanomedicine to enhance anti-tumor immunotherapy following incomplete photothermal ablation","volume":"22","author":"Jiang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"17","key":"10.1016\/j.canlet.2026.218586_bib131","article-title":"Biomimetic nanocarriers guide extracellular ATP homeostasis to remodel energy metabolism for activating innate and adaptive immunity system","volume":"9","author":"Wu","year":"2022","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"10.1016\/j.canlet.2026.218586_bib132","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtm.2021.03.001","article-title":"Targeted knockdown of the adenosine A2A receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cells","volume":"21","author":"Newton","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.canlet.2026.218586_bib133","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2016.01.042","article-title":"A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells","volume":"225","author":"Warashina","year":"2016","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"6","key":"10.1016\/j.canlet.2026.218586_bib134","article-title":"Exosomes in tumor-stroma crosstalk: shaping the immune microenvironment in colorectal cancer","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"4","key":"10.1016\/j.canlet.2026.218586_bib135","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/acsnano.3c10117","article-title":"Mitochondrial disruption nanosystem simultaneously depressed programmed death ligand-1 and transforming growth factor-\u03b2 to overcome photodynamic immunotherapy resistance","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.canlet.2026.218586_bib136","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1021\/jacsau.3c00156","article-title":"Antitumor effects of a distinct sonodynamic nanosystem through enhanced induction of immunogenic cell death and ferroptosis with modulation of tumor microenvironment","volume":"3","author":"Yuan","year":"2023","journal-title":"JACS Au"},{"issue":"7","key":"10.1016\/j.canlet.2026.218586_bib137","doi-asserted-by":"crossref","first-page":"10742","DOI":"10.1021\/acsnano.2c02605","article-title":"Biomimetic nanoplatform loading type I aggregation-induced emission photosensitizer and glutamine blockade to regulate nutrient partitioning for enhancing antitumor immunotherapy","volume":"16","author":"Xie","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218586_bib138","article-title":"In situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response","volume":"26","author":"Chellen","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"22","key":"10.1016\/j.canlet.2026.218586_bib139","article-title":"Design of PD-L1-Targeted lipid nanoparticles to turn on PTEN for efficient cancer therapy","volume":"11","author":"Kim","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger."},{"issue":"23","key":"10.1016\/j.canlet.2026.218586_bib140","article-title":"Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger."},{"issue":"11","key":"10.1016\/j.canlet.2026.218586_bib141","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41565-023-01453-9","article-title":"Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2026.218586_bib142","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jconrel.2023.04.027","article-title":"Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication","volume":"357","author":"Zhao","year":"2023","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.canlet.2026.218586_bib143","first-page":"438","article-title":"Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics","volume":"23","author":"Yang","year":"2023","journal-title":"Bioact. Mater."},{"issue":"19","key":"10.1016\/j.canlet.2026.218586_bib144","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1039\/D2BM01181F","article-title":"A polymeric IDO inhibitor based on poly(ethylene glycol)-b-poly(L-tyrosine-co-1-methyl-D-tryptophan) enables facile trident cancer immunotherapy","volume":"10","author":"Liu","year":"2022","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.canlet.2026.218586_bib145","article-title":"Remodeling tumor-associated neutrophils to enhance dendritic cell-based HCC neoantigen nano-vaccine efficiency","volume":"9","author":"Wang","year":"2022","journal-title":"Adv Sci Weinh Baden-Wurtt Ger."},{"key":"10.1016\/j.canlet.2026.218586_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120190","article-title":"Oxaliplatin-\/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer","volume":"255","author":"Shen","year":"2020","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.canlet.2026.218586_bib147","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2005191118","article-title":"Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through toll-like receptor 4 signaling","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218586_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101967","article-title":"Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database","volume":"59","author":"Zhou","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib149","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ijc.34332","article-title":"Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: a pharmacovigilance analysis","volume":"152","author":"Gu","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib150","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114073","article-title":"Modulation of intrinsic inhibitory checkpoints using nano-carriers to unleash NK cell activity","volume":"14","author":"Biber","year":"2022","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.canlet.2026.218586_bib151","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1021\/acsnano.3c11186","article-title":"Immunomodulatory prodrug micelles imitate mild heat effects to reshape tumor microenvironment for enhanced cancer immunotherapy","volume":"18","author":"Ngo","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib152","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/ijms25031396","article-title":"Nanoparticle-based immunotherapy for reversing T-cell exhaustion","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2026.218586_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax5032","article-title":"Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer","volume":"6","author":"Huang","year":"2020","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.canlet.2026.218586_bib154","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1021\/acsnano.8b02446","article-title":"M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors","volume":"12","author":"Choo","year":"2018","journal-title":"ACS Nano"},{"issue":"21","key":"10.1016\/j.canlet.2026.218586_bib155","doi-asserted-by":"crossref","first-page":"10350","DOI":"10.1039\/D3NR04806C","article-title":"Engineered nanomicelles targeting proliferation and angiogenesis inhibit tumour progression by impairing the synthesis of ceramide-1-phosphate","volume":"16","author":"Yadav","year":"2024","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib156","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/j.apsb.2023.07.012","article-title":"Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.canlet.2026.218586_bib157","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41565-022-01225-x","article-title":"Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration","volume":"17","author":"Yang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.canlet.2026.218586_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.693709","article-title":"The use of iron oxide nanoparticles to reprogram macrophage responses and the immunological tumor microenvironment","volume":"12","author":"Mulens-Arias","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218586_bib159","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218586_bib160","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/cas.15497","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"113","author":"Nagasaki","year":"2022","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.canlet.2026.218586_bib161","doi-asserted-by":"crossref","first-page":"17549","DOI":"10.1021\/acsnano.1c04456","article-title":"Nanoparticle-mediated in situ molecular reprogramming of immune checkpoint interactions for cancer immunotherapy","volume":"15","author":"Walters","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218586_bib162","article-title":"Activation of the DDR pathway leads to the down-regulation of the TGF\u03b2 pathway and a better response to ICIs in patients with metastatic urothelial carcinoma","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218586_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102684","article-title":"Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase","volume":"73","author":"Shen","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"7","key":"10.1016\/j.canlet.2026.218586_bib164","article-title":"Self-blockade of PD-L1 with bacteria-derived outer-membrane vesicle for enhanced cancer immunotherapy","volume":"34","author":"Pan","year":"2022","journal-title":"Adv Mater Deerfield Beach Fla"},{"issue":"717","key":"10.1016\/j.canlet.2026.218586_bib165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2712","article-title":"Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy","volume":"15","author":"Cao","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218586_bib166","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.1021\/acsnano.1c02391","article-title":"Immunosuppressive nanoparticles for management of immune-related adverse events in liver","volume":"15","author":"Shen","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1837","article-title":"New advances in pharmaceutical strategies for sensitizing anti-PD-1 immunotherapy and clinical research","volume":"15","author":"Jiang","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218586_bib168","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/pharmaceutics14081581","article-title":"Recent advances in nanoparticles-based platforms targeting the PD-1\/PD-L1 pathway for cancer treatment","volume":"14","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218586_bib169","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-024-01566-1","article-title":"Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant","volume":"17","author":"Chai","year":"2024","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.canlet.2026.218586_bib170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2023.08.006","article-title":"Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment","volume":"361","author":"Nguyen","year":"2023","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"14","key":"10.1016\/j.canlet.2026.218586_bib171","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1039\/D2BM00650B","article-title":"Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy","volume":"10","author":"Tian","year":"2022","journal-title":"Biomater. Sci."},{"issue":"47","key":"10.1016\/j.canlet.2026.218586_bib172","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/47\/475101","article-title":"Bottom-up engineering of the surface roughness of nanostructured cubic zirconia to control cell adhesion","volume":"23","author":"Singh","year":"2012","journal-title":"Nanotechnology"},{"issue":"34","key":"10.1016\/j.canlet.2026.218586_bib173","article-title":"Metal-coordinated NIR-II nanoadjuvants with nanobody conjugation for potentiating immunotherapy by tumor metabolism reprogramming","volume":"11","author":"Dai","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger."},{"issue":"11","key":"10.1016\/j.canlet.2026.218586_bib174","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1021\/acsnano.9b05974","article-title":"Nanoscale coordination polymer based nanovaccine for tumor immunotherapy","volume":"13","author":"Zhao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218586_bib175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biomaterials.2019.03.020","article-title":"Highly efficient cascading synergy of cancer photo-immunotherapy enabled by engineered graphene quantum dots\/photosensitizer\/CpG oligonucleotides hybrid nanotheranostics","volume":"205","author":"Wu","year":"2019","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.canlet.2026.218586_bib176","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/med.21971","article-title":"(nano)platforms in breast cancer therapy: drug\/gene delivery, advanced nanocarriers and immunotherapy","volume":"43","author":"Ashrafizadeh","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"8","key":"10.1016\/j.canlet.2026.218586_bib177","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.hlife.2024.06.002","article-title":"Boosting CAR-T cell therapy with CRISPR technology","volume":"2","author":"Yan","year":"2024","journal-title":"hLife"},{"issue":"2","key":"10.1016\/j.canlet.2026.218586_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/mef2.79","article-title":"Current progress in chimeric antigen receptor T-cell therapy for malignant tumors","volume":"3","author":"Zheng","year":"2024","journal-title":"MedComm \u2013 Future Med."},{"issue":"37","key":"10.1016\/j.canlet.2026.218586_bib179","article-title":"CAR T cell membrane camouflaged nanocatalyst augments CAR T cell therapy efficacy against solid tumor","volume":"20","author":"Wu","year":"2024","journal-title":"Small Weinh Bergstr Ger"},{"key":"10.1016\/j.canlet.2026.218586_bib180","author":"Piek"},{"key":"10.1016\/j.canlet.2026.218586_bib181","unstructured":"Radboud University Medical Center. Trained immunity of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma and colon carcinoma [clinical trial registration] [internet]. [cited 2026 February 6], clinicaltrials.gov; 2025 Dec. Clinical trial registration no.: NCT05280379. Available from:: https:\/\/clinicaltrials.gov\/study\/NCT05280379."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:25:25Z","timestamp":1783437925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":181,"alternative-id":["S0304383526003496"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218586","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine orchestrated metabolic reprogramming of immune cells in antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218586"}}